User login
Antibiotic resistance causes 2 million illnesses and about 23,000 deaths each year in the U.S. and limits the ability to perform a range of medical procedures, including chemotherapy, surgery, and organ transplants, according to the HHS.
In response to this very real threat, on March 27, 2015, HHS released the National Action Plan for Combating Antibiotic Resistant Bacteria (NAP). HHS Secretary Sylvia M. Burwell, U.S. Department of Agriculture Secretary Tom Vilsack, and U.S. Defense Secretary Ash Carter describe NAP as a “whole-of-government approach,” requiring a long-term commitment over the next 5 years to:
- Slow the emergence of resistant bacteria and prevent the spread of resistant infections
- Strengthen national “One-Health” surveillance efforts
- Advance development and use of rapid and innovative diagnostic tests
- Accelerate basic and applied research and development
- Improve international collaboration and capacities
Related: Distinguishing Influenza From Bacterial Infection
The NAP outlines each of these 5 goals in detail, and 1-, 3-, and 5-year milestones benchmark many of the goals’ multiple objectives. Much of the 1-year milestones describe research, data collection, and the enhancement or establishment of interdepartmental and international cooperative data sharing; whereas much of the 3- and 5-year milestones describe ongoing research, data reporting, revised regulations, and measurement of the impact that any and all revised strategies have had or will have on the ultimate goal of combating antibiotic resistant bacteria worldwide.
Related: Antibiotic Failure: Not Only a Hospital Phenomenon
President Obama first outlined NAP in his September 2014 Executive Order, Combating Antibiotic-Resistant Bacteria. The NAP is part of the more than $1.2 billion proposed in the President’s fiscal year 2016 budget for combating and preventing antibiotic resistance.
Related: Global Health Cooperation
The coordinated approach to accomplishing NAP’s goals will require efforts of individuals and groups around the world, including public and private sector partners, health care providers, health care leaders, veterinarians, agriculture industry leaders, manufacturers, policymakers, and patients.
Antibiotic resistance causes 2 million illnesses and about 23,000 deaths each year in the U.S. and limits the ability to perform a range of medical procedures, including chemotherapy, surgery, and organ transplants, according to the HHS.
In response to this very real threat, on March 27, 2015, HHS released the National Action Plan for Combating Antibiotic Resistant Bacteria (NAP). HHS Secretary Sylvia M. Burwell, U.S. Department of Agriculture Secretary Tom Vilsack, and U.S. Defense Secretary Ash Carter describe NAP as a “whole-of-government approach,” requiring a long-term commitment over the next 5 years to:
- Slow the emergence of resistant bacteria and prevent the spread of resistant infections
- Strengthen national “One-Health” surveillance efforts
- Advance development and use of rapid and innovative diagnostic tests
- Accelerate basic and applied research and development
- Improve international collaboration and capacities
Related: Distinguishing Influenza From Bacterial Infection
The NAP outlines each of these 5 goals in detail, and 1-, 3-, and 5-year milestones benchmark many of the goals’ multiple objectives. Much of the 1-year milestones describe research, data collection, and the enhancement or establishment of interdepartmental and international cooperative data sharing; whereas much of the 3- and 5-year milestones describe ongoing research, data reporting, revised regulations, and measurement of the impact that any and all revised strategies have had or will have on the ultimate goal of combating antibiotic resistant bacteria worldwide.
Related: Antibiotic Failure: Not Only a Hospital Phenomenon
President Obama first outlined NAP in his September 2014 Executive Order, Combating Antibiotic-Resistant Bacteria. The NAP is part of the more than $1.2 billion proposed in the President’s fiscal year 2016 budget for combating and preventing antibiotic resistance.
Related: Global Health Cooperation
The coordinated approach to accomplishing NAP’s goals will require efforts of individuals and groups around the world, including public and private sector partners, health care providers, health care leaders, veterinarians, agriculture industry leaders, manufacturers, policymakers, and patients.
Antibiotic resistance causes 2 million illnesses and about 23,000 deaths each year in the U.S. and limits the ability to perform a range of medical procedures, including chemotherapy, surgery, and organ transplants, according to the HHS.
In response to this very real threat, on March 27, 2015, HHS released the National Action Plan for Combating Antibiotic Resistant Bacteria (NAP). HHS Secretary Sylvia M. Burwell, U.S. Department of Agriculture Secretary Tom Vilsack, and U.S. Defense Secretary Ash Carter describe NAP as a “whole-of-government approach,” requiring a long-term commitment over the next 5 years to:
- Slow the emergence of resistant bacteria and prevent the spread of resistant infections
- Strengthen national “One-Health” surveillance efforts
- Advance development and use of rapid and innovative diagnostic tests
- Accelerate basic and applied research and development
- Improve international collaboration and capacities
Related: Distinguishing Influenza From Bacterial Infection
The NAP outlines each of these 5 goals in detail, and 1-, 3-, and 5-year milestones benchmark many of the goals’ multiple objectives. Much of the 1-year milestones describe research, data collection, and the enhancement or establishment of interdepartmental and international cooperative data sharing; whereas much of the 3- and 5-year milestones describe ongoing research, data reporting, revised regulations, and measurement of the impact that any and all revised strategies have had or will have on the ultimate goal of combating antibiotic resistant bacteria worldwide.
Related: Antibiotic Failure: Not Only a Hospital Phenomenon
President Obama first outlined NAP in his September 2014 Executive Order, Combating Antibiotic-Resistant Bacteria. The NAP is part of the more than $1.2 billion proposed in the President’s fiscal year 2016 budget for combating and preventing antibiotic resistance.
Related: Global Health Cooperation
The coordinated approach to accomplishing NAP’s goals will require efforts of individuals and groups around the world, including public and private sector partners, health care providers, health care leaders, veterinarians, agriculture industry leaders, manufacturers, policymakers, and patients.